A new device called Neubond, a wearable technology for stroke rehab from a spin-off company formed at Imperial College is now in research & testing phase. Neubond is a closed-loop system built on a technology called Volition-Induced Paired Associative Stimulation (VIPAS). PAS differs from FES as FES is an open-loop system.
The lightweight, comfortable bracelet is equipped with tiny sensors that can detect the very subtle electrical signals your brain sends when you try to move your affected limb, even if you can’t see or feel the movement yet. At the precise moment your brain is sending that command, Neubond delivers a gentle electrical stimulation to the corresponding muscle. This reinforces the neural pathway and helps your brain re-learn. By repeatedly pairing your intention to move with the actual movement, the device essentially helps to rewire your brain, promoting plasticity and strengthening that vital brain-to-muscle connection over time.
Neubond is a discreet, comfortable wearable, therapy can happen anytime, anywhere. The user is no longer limited to short clinical sessions… this continuous, everyday practice is key to maximising ones recovery potential.
Linked to a mobile app, Neubond tracks your muscle activity and provides data-driven insights for both you and your clinicians. This makes progress visible and motivating, turning small gains into big milestones. Users in trials have reported regaining the ability to do small but incredibly significant things, like handwriting or even cuddling a grandchild. These personal victories ignite hope and show that meaningful recovery is possible.
Neubond is an exciting step forward in making neurorehab more accessible, effective, and human. The wearable is still in the testing and development phase and is not currently available for stroke survivors to purchase but as of recent reports, Neubond is working to turn its prototype into a production-ready device and conducting clinical testing to prepare for randomised clinical trials. The company plans to first release a version of the device that monitors movement intention and guides rehabilitation by providing visual feedback to the user. This version will require a less demanding regulatory process than the full therapeutic device.
Their website holds a waiting list for early access to pilot and beta testing, which you can join if you are interested in potentially participating in future trials.
